Mania Clinical Trial
Official title:
A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo Controlled, Phase III Study of the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) Sustained-Release as Monotherapy in Adult Patients With Acute Bipolar Mania
The purpose of this study is to determine the safety and efficacy of sustained-release
quetiapine fumarate (Seroquel®) in the treatment of patients with Acute Bipolar Mania for 3
weeks.
PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation
was changed to XR after consultation with FDA.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05206747 -
Ottawa Sunglasses at Night for Mania Study
|
N/A | |
Completed |
NCT00534222 -
Unraveling the Relation of Patient's Profile and Therapeutical Effects of Atypicals, Including Quetiapine Effect
|
N/A | |
Completed |
NCT00140179 -
Valnoctamide in Mania
|
Phase 3 | |
Completed |
NCT01237379 -
Peroxisomal Defects and Familial Risk for Bipolar Disorder
|
N/A | |
Completed |
NCT01315028 -
Bipolar Intervention Study: Cognitive Interpersonal Therapy
|
N/A | |
Completed |
NCT00254488 -
Treatment of Bipolar Mania in Older Adults
|
Phase 4 | |
Completed |
NCT00560079 -
Efficacy of Allopurinol and Dypiridamole in Acute Mania
|
Phase 4 | |
Completed |
NCT00518947 -
Pharmacotherapy of Treatment-Resistant Mania
|
Phase 3 | |
Recruiting |
NCT05444907 -
Deep Brain Stimulation-Induced Mania in Parkinson's Disease
|
||
Enrolling by invitation |
NCT02360267 -
Pediatric Bipolar Registry
|
||
Completed |
NCT01092221 -
Allopurinol for Mania: A Randomized Trial Administering Allopurinol vs. Placebo as add-on to Mood Stabilizers and/or Antipsychotics in Patients in a Bipolar Manic Episode
|
Phase 3 | |
Completed |
NCT00521365 -
Effectiveness of Quetiapine XR on the Control of Symptoms of Manic Phase of Bipolar Disorder.
|
Phase 4 | |
Completed |
NCT01191918 -
The Efficacy and Safety of AChE Inhibitor Donepezil As Adjunctive Treatment to Mood Stabilizers in Acute Mania
|
Phase 4 | |
Completed |
NCT01541605 -
Methylphenidate for the Treatment of Acute Mania
|
Phase 3 | |
Completed |
NCT00893581 -
Multimodal Neuroimaging of Treatment Effects in Adolescent Mania
|
N/A | |
Completed |
NCT00208195 -
Depakote ER Therapy for Mania Comorbid With Substance Abuse
|
Phase 4 | |
Completed |
NCT00181922 -
Ziprasidone for the Treatment of Mania in Children and Adolescents With Bipolar Disorder
|
Phase 4 | |
Completed |
NCT00181935 -
Risperidone Versus Olanzapine for Mania in Preschool Children 4 to 6 Years of Age With Bipolar Disorder
|
Phase 4 | |
Active, not recruiting |
NCT05703711 -
Combining mHealth and Nurse-delivered Care to Improve the Outcomes of People With Serious Mental Illness in West Africa
|
N/A | |
Completed |
NCT00917501 -
Neurochemical Effects of Omega-3 Fatty Acids in Adolescents at Risk for Mania
|
Phase 2 |